125 related articles for article (PubMed ID: 38526005)
1. The evolution and impact of sarcopenia in severe aplastic anaemia survivors following allogeneic haematopoietic cell transplantation.
Chen D; Yuan Z; Guo Y; Liu W; Cheng Z; Ye L; Mo W; Wei X
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1094-1107. PubMed ID: 38526005
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Quantifying Sarcopenia and Adipopenia by Chest CT in Severe Aplastic Anemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation.
Chen D; Yuan Z; Guo Y; Mo W; Liu W; Liang D; Chen A; Zhang Y; Zhang N; Wei X
Acad Radiol; 2023 Sep; 30(9):1936-1945. PubMed ID: 36379814
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].
Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835
[No Abstract] [Full Text] [Related]
4. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
[TBL] [Abstract][Full Text] [Related]
5. Exploring strategies to optimise outcomes in hepatitis-associated aplastic anaemia patients following haematopoietic stem cell transplantation.
Li J; Liu Y; Wang J; Wang Y; Pang A; Yang D; Chen X; Zhang R; Wei J; Ma Q; Zhai W; He Y; Jiang E; Han M; Feng S
Sci Rep; 2024 Mar; 14(1):5178. PubMed ID: 38431738
[TBL] [Abstract][Full Text] [Related]
6. Graft-
Devillier R; Eikema DJ; Dufour C; Aljurf M; Wu D; Maschan A; Kulagin A; Halkes CJM; Collin M; Snowden J; Renard C; Ganser A; Sykora KW; Gibson BE; Maertens J; Itäla-Remes M; Corti P; Cornelissen J; Bornhäuser M; Araujo MC; Ozdogu H; Risitano A; Socie G; De Latour RP
Haematologica; 2023 Sep; 108(9):2305-2315. PubMed ID: 36951165
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study.
Zhang Y; Chen X; Yang D; Pang A; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Feng S
Front Immunol; 2022; 13():1004787. PubMed ID: 36172387
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
DeFilipp Z; Troschel FM; Qualls DA; Li S; Kuklinski MW; Kempner ME; Hochberg E; Chen YB; El-Jawahri A; Fintelmann FJ
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1741-1747. PubMed ID: 29496561
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor.
Niu YY; Ma LM; Wang T
Transfus Clin Biol; 2022 Feb; 29(1):53-59. PubMed ID: 34343707
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 76 patients with severe aplastic anemia treated with haploid hematopoietic stem cell transplantation].
Zhang Y; Zhang GX; Pang AM; Yang DL; Zhang RL; Zhai WH; Wei JL; He Y; Jiang EL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):202-210. PubMed ID: 37356981
[No Abstract] [Full Text] [Related]
12. Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study.
Liu L; Miao M; He H; Wang S; Zhang Y; Guo A; Jiao W; Lei M; Cai Y; Shangguan X; Liu Z; Xu J; Li X; Zhang L; Wu D
Front Immunol; 2022; 13():955095. PubMed ID: 36131940
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen.
Li L; Li Y; Lin L; Yin J; Xu J; Wei J; Zhang Y
Ann Hematol; 2020 Aug; 99(8):1863-1871. PubMed ID: 32556453
[TBL] [Abstract][Full Text] [Related]
14. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation.
Xu LP; Yu Y; Cheng YF; Zhang YY; Mo XD; Han TT; Wang FR; Yan CH; Sun YQ; Chen YH; Wang JZ; Xu ZL; Tang FF; Han W; Wang Y; Zhang XH; Huang XJ
Br J Haematol; 2022 Feb; 196(3):735-742. PubMed ID: 34741461
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
Front Immunol; 2022; 13():837335. PubMed ID: 35178053
[TBL] [Abstract][Full Text] [Related]
18. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.
Kudo K; Muramatsu H; Yoshida N; Kobayashi R; Yabe H; Tabuchi K; Kato K; Koh K; Takahashi Y; Hashii Y; Kawano Y; Inoue M; Cho Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
Bone Marrow Transplant; 2015 Oct; 50(10):1312-5. PubMed ID: 26121106
[TBL] [Abstract][Full Text] [Related]
19. Impact of Iron Overload and Iron Chelation with Deferasirox on Outcomes of Patients with Severe Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Pan T; Ji Y; Liu H; Tang B; Song K; Wan X; Yao W; Sun G; Wang J; Sun Z
Transplant Cell Ther; 2023 Aug; 29(8):507.e1-507.e8. PubMed ID: 37116582
[TBL] [Abstract][Full Text] [Related]
20. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D
Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
